HER2 Positive Breast Cancer

Book HER2 Positive Breast Cancer Cover

Read or download book entitled HER2 Positive Breast Cancer written by Sara Hurvitz and published by Elsevier Health Sciences in PDF, EPUB and Kindle Format. Click Get This Book button to download or read online books. Join over 650.000 happy Readers and READ as many books as you like. We cannot guarantee that HER2 Positive Breast Cancer book is available in the library.

  • Publisher : Elsevier Health Sciences
  • Release : 26 July 2018
  • ISBN : 9780323581233
  • Page : 264 pages
  • Rating : 4.5/5 from 103 voters

Download HER2 Positive Breast Cancer in PDF, Epub and Kindle

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.

GET THIS BOOK

HER2-Positive Breast Cancer

HER2-Positive Breast Cancer
  • Author : Sara Hurvitz,Kelly McCann
  • Publisher : Elsevier Health Sciences
  • Release Date : 2018-07-26
  • ISBN : 9780323581233
GET THIS BOOKHER2-Positive Breast Cancer

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.

HER2-Positive Breast Cancer

HER2-Positive Breast Cancer
  • Author : Sara Hurvitz,Kelly McCann
  • Publisher : Elsevier
  • Release Date : 2018-08
  • ISBN : 0323581226
GET THIS BOOKHER2-Positive Breast Cancer

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today's available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists. Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive. Contains sections on background and testing,

Central Nervous System Metastases

Central Nervous System Metastases
  • Author : Manmeet Ahluwalia,Philippe Metellus,Riccardo Soffietti
  • Publisher : Springer Nature
  • Release Date : 2019-11-05
  • ISBN : 9783030234171
GET THIS BOOKCentral Nervous System Metastases

This book provides a comprehensive overview of brain metastases, from the molecular biology aspects to therapeutic management and perspectives. Due to the increasing incidence of these tumors and the urgent need to effectively control brain metastatic diseases in these patients, new therapeutic strategies have emerged in recent years. The volume discusses all these innovative approaches combined with new surgical techniques (fluorescence, functional mapping, integrated navigation), novel radiation therapy techniques (stereotactic radiosurgery) and new systemic treatment approaches such as targeted- and

Targeted Therapies in Breast Cancer

Targeted Therapies in Breast Cancer
  • Author : George W. Sledge, Jr.,Jose Baselga
  • Publisher : Unknown
  • Release Date : 2013-04-15
  • ISBN : 1846920663
GET THIS BOOKTargeted Therapies in Breast Cancer

This new volume updates the reader on selected areas of targeted therapy in breast cancer, with special emphasis on chemoprevention strategies, drug resistance, biomarkers, combination chemotherapy, angiogenesis inhibition and pharmacogenomics in the context of clinical efficacy. This selected review of targeted therapies will guide the reader on effective treatment as part of an integrated programme of patient management.

Abeloff's Clinical Oncology E-Book

Abeloff's Clinical Oncology E-Book
  • Author : Martin D. Abeloff,James O. Armitage,John E. Niederhuber,Michael B. Kastan,W. Gillies McKenna
  • Publisher : Elsevier Health Sciences
  • Release Date : 2008-06-30
  • ISBN : 9781437720563
GET THIS BOOKAbeloff's Clinical Oncology E-Book

Carrying on the tradition established by its founding editor, the late Dr. Martin Abeloff, the 4th Edition of this respected reference synthesizes all of the latest oncology knowledge in one practical, clinically focused, easy-to-use volume. It incorporates basic science, pathology, diagnosis, management, outcomes, rehabilitation, and prevention – all in one convenient resource – equipping you to overcome your toughest clinical challenges. What's more, you can access the complete contents of this Expert Consult title online, and tap into its unparalleled guidance wherever

Her-2

Her-2
  • Author : Robert Bazell
  • Publisher : Random House
  • Release Date : 2011-04-27
  • ISBN : 9780307764980
GET THIS BOOKHer-2

Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation,

Take Control of Your Cancer Risk

Take Control of Your Cancer Risk
  • Author : John Whyte, MD, MPH
  • Publisher : Harper Horizon
  • Release Date : 2021-10-05
  • ISBN : 9780785240419
GET THIS BOOKTake Control of Your Cancer Risk

Something everyone has the power to do is reduce your cancer risk, and this book will show you just how easy it is to do it. Each year, over a million people in the United States alone hear the words no one ever wants to hear: You have cancer. But what if there was a way for fewer people to hear these words? One of the biggest myths regarding cancer is that it’s mostly genetic - meaning that you

Sentinel Lymph Node Biopsy

Sentinel Lymph Node Biopsy
  • Author : Hiram S. Cody
  • Publisher : CRC Press
  • Release Date : 2001-11-08
  • ISBN : 1841840343
GET THIS BOOKSentinel Lymph Node Biopsy

An intuitive, ingenious and powerful technique, sentinel lymph node biopsy has entered clinical practice with astonishing rapidity and now represents a new standard of care for melanoma and breast cancer patients, while showing great promise for the treatment of urologic, colorectal, gynecologic, and head and neck cancers. This text, written by international experts in the technique, provides a clear and comprehensive guide, presenting a detailed overview and discussing the various mapping techniques available and how these are applied in a

Neo-adjuvant Chemotherapy

Neo-adjuvant Chemotherapy
  • Author : Claude Jacquillat,Marise Weil,David Khayat,Institut national de la santé et de la recherche médicale (France)
  • Publisher : John Libbey Eurotext
  • Release Date : 1988
  • ISBN : 0861961501
GET THIS BOOKNeo-adjuvant Chemotherapy

This book presents the Proceedings of the Second International Congress on Neo-Adjuvant Chemotherapy which took place on 19 to 21 February 1988 in Paris.

100 Questions & Answers About Advanced & Metastatic Breast Cancer

100 Questions & Answers About Advanced & Metastatic Breast Cancer
  • Author : Lillie D. Shockney,Gary R. Shapiro
  • Publisher : Jones & Bartlett Publishers
  • Release Date : 2011-06
  • ISBN : 9781449643362
GET THIS BOOK100 Questions & Answers About Advanced & Metastatic Breast Cancer

EMPOWER YOURSELF! Whether you're a newly diagnosed patient, survivor, or loved one of someone suffering from advanced breast cancer, 100 Questions & Answers About Advanced and Metastatic Breast Cancer, Second Edition offers essential and practical guidance. Providing both doctor and patient perspectives, this updated and revised edition offers authoritative answers to the most commonly asked questions about advanced and metastatic breast cancer including diagnosis, treatment, post-treatment quality of life, alternative medicine, targeted therapy, and coping strategies. Written by experts from Johns Hopkins

Preoperative (Neoadjuvant) Chemotherapy

Preoperative (Neoadjuvant) Chemotherapy
  • Author : Joseph Ragaz,Pierre R. Band,James H. Goldie
  • Publisher : Springer Science & Business Media
  • Release Date : 2012-12-06
  • ISBN : 9783642826719
GET THIS BOOKPreoperative (Neoadjuvant) Chemotherapy

Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. Pre operative (neoadjuvant) chemotherapy represents a new approach in drug scheduling, based on sound theoretical, pharmacokinetic, and experimental principles. The preoperative timing of chemotherapy before definitive sur gery is not a minor change in the therapy of cancer. To be successful, large numbers of practitioners and their patients must participate. Substantial alterations

Nuclear Oncology

Nuclear Oncology
  • Author : Cumali Aktolun,W. Newlon Tauxe
  • Publisher : Springer Science & Business Media
  • Release Date : 2012-12-06
  • ISBN : 9783642586439
GET THIS BOOKNuclear Oncology

Nuclear Oncology describes the use of radionuclides in the diagnosis and management of malignant tumors. Both in vivo and in vitro techniques are included. The book was written by an international panel of authors, most, if not all, of whom are the pioneers of the techniques described. Their chapters reflect the universal views in the field of nuclear medicine and oncology. Clinical aspects and technical details are presented for both standard and new nuclear oncological techniques, including breast scintigraphy, receptor

The Breast Cancer Survival Manual, Fifth Edition

The Breast Cancer Survival Manual, Fifth Edition
  • Author : John Link, M.D.
  • Publisher : Holt Paperbacks
  • Release Date : 2012-08-07
  • ISBN : 9781429961486
GET THIS BOOKThe Breast Cancer Survival Manual, Fifth Edition

The updated edition of the essential resource for the 250,000 women diagnosed with breast cancer each year Breast cancer is the leading cause of death in women from thirty-five to fifty-four years of age, and few things are as terrifying and confusing as a diagnosis of this disease. The fifth edition of The Breast Cancer Survival Manual is a concise, information-packed guide that is newly revised to contain all of the latest findings to help the woman facing treatment feel informed

Optimising the Role of Herceptin in Breast Cancer

Optimising the Role of Herceptin in Breast Cancer
  • Author : David Khayat
  • Publisher : S Karger Ag
  • Release Date : 2001-01-01
  • ISBN : 3805573278
GET THIS BOOKOptimising the Role of Herceptin in Breast Cancer

The humanised monoclonal antibody Herceptin® targets human epidermal growth factor receptor-2 (HER2) positive cells, i.e. cells in which HER2 is overexpressed, a feature associated with many tumour characteristics. Approximately 20-30% of breast cancers are HER2 positive and are known to be particularly aggressive. Thus, HER2-positive clinical trials of Herceptin® have clearly demonstrated that it provides significant clinical benefit in HER2-positive metastatic dis-ease, most importantly increased survival when administered first line in combination with chemotherapy. The articles in

Targeted Therapies in Breast Cancer

Targeted Therapies in Breast Cancer
  • Author : Harold J. Burstein
  • Publisher : Oxford American Pocket Notes
  • Release Date : 2011
  • ISBN : 9780199735679
GET THIS BOOKTargeted Therapies in Breast Cancer

The development of monoclonal antibodies and other inhibitors of specific molecules, fully utilizing the insights learned from molecular techniques such as comparative microarrays and protein expression patterns, has led to the development and FDA approval of several agents for the treatment of breast cancer, such as trastuzamab (Herceptin, targeting HER-2 positive tumors) and lapatinib (Tykerb, targeting tumors with mutated/overexpressed EGFR 1 and 2). Other agents specifically targeting the estrogen receptor, the aromatose pathway and microtubule dynamics, fulvestrant (Faslodex, targeting the ER